Research that is free to access for all investors. Companies commission these providers to write research about them.
Brokers who write research on their corporate clients and make it available through our main bundle offering.
Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.
Event in Progress:
Mark Brewer
4 pages
Circassia Pharmaceuticals (CIR): Corp Board changes – transition to the next phase of growth | Evgen Pharma (EVG): Corp Investigator-led study in NASH
Companies: TheraCryf PLC
Companies: REASEE0RXCMHSCELWBARBBSIXHTONWHIMURAGYCLIGINLGDRSDITRXSCLPCOSTIMESUMOAVODNLOXBVALYGENABZANSFTCFSPEGTLYYU/PHPAVCTMCLPPHBURWBIDVLKYYWY
Companies: KOO MYE0 GNS FDBK AMS SN/ EKF ANCR FUM TSTL HIK CVSG SCLP COG HVO CTEC OXB DXRX NIOX SPI IHC AVCT HCM OHGR AREC OPT
Companies: BNO0RXCMHRE/SCESOGARBBSIXHTONVP/MURAGYEOGCLIGTPTINLGDRTRXSCLPCOSTIMEAVODNLOXBKOOVTETVALYGENABZANSFTCFGTLYPHPAVCTFUTRMCLBURWBIDVLSSY
